Skip to content

Drug interactions

Metformin-repaglinide + Risdiplam

Severity: Moderate

Metformin-repaglinide and Risdiplam: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Risdiplam inhibits the renal MATE transporters that clear metformin, so metformin exposure can rise. Higher metformin levels increase the risk of gastrointestinal effects and, in susceptible patients, lactic acidosis.

What this interaction means in plain words

Metformin-repaglinide and Risdiplam can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Metformin-repaglinide belongs to Endocrine; Risdiplam belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Risdiplam inhibits MATE1 and MATE2-K, reducing renal tubular secretion of metformin.

What to do

Monitor glycemic control and renal function and consider lowering the metformin dose if the combination is needed. Watch for signs of lactic acidosis.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Metformin-repaglinide and Risdiplam, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Metformin-repaglinide with Risdiplam?

MediHelp rates the interaction as moderate. Metformin-repaglinide and Risdiplam can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Risdiplam inhibits the renal MATE transporters that clear metformin, so metformin exposure can rise. Higher metformin levels increase the risk of gastrointestinal effects and, in susceptible patients, lactic acidosis.

How serious is the interaction between Metformin-repaglinide and Risdiplam?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glycemic control and renal function and consider lowering the metformin dose if the combination is needed. Watch for signs of lactic acidosis.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in